Differential efficacy of nicotine replacement among overweight and obese women smokers.
Introduction Rates of obesity are higher among more dependent smokers and 37-65% of smokers seeking cessation treatment are overweight or obese. Overweight or obese smokers may possess metabolic and neurobiological features that contribute to difficulty achieving cessation using front-line nicotine...
Päätekijät: | Strong, DR, David, S, Johnstone, E, Aveyard, P, Murphy, M, Munafò, M |
---|---|
Aineistotyyppi: | Journal article |
Kieli: | English |
Julkaistu: |
2014
|
Samankaltaisia teoksia
-
Effect on adherence to nicotine replacement therapy of informing smokers their dose is determined by their genotype: a randomised controlled trial.
Tekijä: Marteau, T, et al.
Julkaistu: (2012) -
Lack of association of DRD2 rs1800497 (Taq1A) polymorphism with smoking cessation in a nicotine replacement therapy randomized trial
Tekijä: Munafo, M, et al.
Julkaistu: (2009) -
Lack of association of DRD2 rs1800497 (Taq1A) polymorphism with smoking cessation in a nicotine replacement therapy randomized trial.
Tekijä: Munafò, MR, et al.
Julkaistu: (2009) -
Effect on adherence to nicotine replacement therapy of informing smokers their dose is determined by their genotype: a randomised controlled trial.
Tekijä: Theresa M Marteau, et al.
Julkaistu: (2012-01-01) -
Genome-wide association for smoking cessation success: participants in the Patch in Practice trial of nicotine replacement.
Tekijä: Uhl, G, et al.
Julkaistu: (2010)